Evaluating Focal Shock Wave Therapy for Muscle-Related Temporomandibular Joint Pain in Adults A Double-Blind Randomized Trial

What this Trial Is About

Researchers are studying the effects of focal extracorporeal shock wave therapy ESWT on adults with temporomandibular disorders TMD that cause muscle pain. The study aims to evaluate pain improvement after 5 weeks of treatment and at 1 and 3 months post-treatment. Secondary goals include assessing jaw movement, joint inflammation, quality of life, and the use of pain medication. Safety will be monitored by tracking any side effects throughout the study. The study involves two groups one receiving real focal shock wave therapy applied weekly for 5 weeks to affected jaw muscles, and the other receiving placebo treatment with a dummy applicator. Both groups will also get guidance from a physiotherapist on habits, stretching, exercises, and ergonomic practices to improve quality of life. Follow-up evaluations will occur at 1, 3, and 6 months after treatment. Participants will undergo assessments including pain measurement using a Visual Analogue Scale, range of motion testing, ultrasound evaluation of inflammation, and questionnaires on quality of life. Jaw movement, joint noise, and pressure pain threshold will be recorded during treatment sessions and follow-ups. Researchers will also compare pain medication use before and after treatment. The total participation includes 5 weeks of treatment and multiple follow-up visits over several months.

Effects of Focal Extracorporeal Shock Wave Therapy in the Treatment of Temporomandibular Disorders of Muscular Origin